Frankfurt - Delayed Quote • EUR
ACADIA Pharmaceuticals Inc. (DR6.F)
At close: 8:22 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAKER BROS ADVISORS L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 1, 2023 | -- |
| BREGE LAURA A Director | Sale | Jun 12, 2023 | 13,502 |
| DAVIS STEPHEN R Chief Executive Officer | Sale | Apr 8, 2024 | 144,267 |
| GAROFALO ELIZABETH A. Director | Stock Gift | Nov 24, 2023 | 15,862 |
| HARRIGAN EDMUND P. M.D. Director | Conversion of Exercise of derivative security | Jun 1, 2023 | 19,002 |
| KIHARA JAMES Officer | Sale | Apr 8, 2024 | 13,100 |
| KIM AUSTIN D. General Counsel | Sale | Jan 8, 2024 | 46,901 |
| NDU ADORA Director | Conversion of Exercise of derivative security | Oct 12, 2023 | 4,381 |
| SCHNEYER MARK C. Chief Financial Officer | Sale | Apr 8, 2024 | 28,742 |
| TEEHAN BRENDAN Chief Operating Officer | Sale | Apr 8, 2024 | 38,796 |
Related Tickers
0OT.F Ocular Therapeutix, Inc.
4.5470
-2.24%
YDO1.F Madrigal Pharmaceuticals, Inc.
190.35
-6.00%
26CA.F ImmunityBio, Inc.
4.4810
-11.44%
1VT.F Viking Therapeutics, Inc.
61.28
+0.59%
OCUL Ocular Therapeutix, Inc.
4.6450
-7.10%
MDGL Madrigal Pharmaceuticals, Inc.
204.65
-6.29%
IBRX ImmunityBio, Inc.
4.8200
-12.20%
VKTX Viking Therapeutics, Inc.
65.07
+0.22%